Posted in | News | Green Energy | Wind Power

Fortum and Skellefteå Kraft to Build Fourth Phase of Blaiken Wind Farm

Fortum and Skellefteå Kraft, a Swedish energy company, will build the fourth phase of the Blaiken wind farm in Sweden consisting in total of 9 wind turbines. Skellefteå Kraft will be responsible for the investment of six of the turbines while Fortum will invest in three turbines. The value of Fortum's investment is approximately EUR 10 million. The new wind turbines are expected to start production in 2017.

With its current 90 wind turbines, Blaiken Wind is one of the biggest onshore wind farms in Europe. Fortum owns 12 of these 90 turbines. Its annual production is estimated to be between 600 and 720 GWh, which is equivalent to the annual electricity consumption of 150,000 households. The construction of the wind farm began in 2011.

Per Langer, Executive Vice President, Hydro power and technology division, Fortum, says that Fortum is very happy to continue the good cooperation with Skellefteå Kraft, which has long experience in wind power production.

Fortum Corporation
Corporate Communications

Further information:
Jens Bjöörn, Senior Manager, Corporate Relations, +46 70 298 41 25

Fortum’s purpose is to create energy that improves life for present and future generations. Fortum’s expertise is in CO2-free and efficient electricity and heat production. The company also offers energy-related products and expert services to private and industrial customers and energy producers. Fortum’s main areas of operation are the Nordic and the Baltic countries, Russia and Poland. In 2014, the annual sales (excluding the divested electricity distribution business) totalled EUR 4.1 billion, and comparable operating profit was EUR 1.1 billion. The company employs approximately 8,000 people. Fortum’s share is listed on Nasdaq Helsinki.


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.